Search company, investor...
BridgePoint Medical company logo

BridgePoint Medical

bridgepointmedical.com

Founded Year

2002

Stage

Acquired | Acquired

Total Raised

$26.2M

About BridgePoint Medical

BridgePoint Medical is focused on developing technology in the field of interventional cardiology for access to and treatment of chronic total occlusions.In September 2012, BridgePoint medical was acquired by Boston Scientific. The valuation of BridgePoint Medical was undisclosed. Other terms of the deal were not released.

Headquarters Location

13355 10th Ave N Suite 110

Plymouth, Minnesota, 55441,

United States

763-225-8500

Missing: BridgePoint Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BridgePoint Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

BridgePoint Medical Patents

BridgePoint Medical has filed 1 patent.

The 3 most popular patent topics include:

  • Vascular diseases
  • Angiology
  • Cardiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/16/2019

11/29/2022

Cannabinoids, Designer drugs, Indoles, Heart diseases, Angiology

Grant

Application Date

9/16/2019

Grant Date

11/29/2022

Title

Related Topics

Cannabinoids, Designer drugs, Indoles, Heart diseases, Angiology

Status

Grant

Latest BridgePoint Medical News

ExplORer Surgical Appoints Senior Advisor

Oct 15, 2020

ExplORer Surgical Appoints Senior Advisor Adds new member to board of directors. ExplORer helps medical device companies and surgical teams reduce variability and bring best practices to life by providing a customized digital playbook software for use during procedures. ExplORer Surgical10.15.20 ExplORer Surgical , a comprehensive intraoperative case support and workflow platform, has named Art Collins, former chairman and CEO of Medtronic, as senior advisor and appointed Denis Harrington, former CEO of BridgePoint Medical, to its Board of Directors. Collins’ and Harrington’s decades of commercial and entrepreneurial experience in the medical device field provide ExplORer Surgical and its executive team a valuable resource to help direct the company's strategy. Collins has over 30 years of experience in the medtech industry, first with Abbott Laboratories and later with Medtronic where he served as chairman & CEO from 2001 to 2008. During his 15-year tenure as CEO and COO of Medtronic, revenues and earnings per share grew at a compounded growth rate of over 15 percent. He is currently a member of Boeing’s board of directors and is past director of Alcoa, Arconic, Cargill, Tennant, and US Bancorp. He also served as a member of the Board of Overseers of the Wharton School at the University of Pennsylvania and as chairman of AdvaMed, the medical technology industry association. “We all know that 2020 has created a new normal for hospitals and medtech companies as they increasingly embrace remote and digital technology. ExplORer was well positioned before the pandemic, and this year has accelerated the demand for their cutting-edge platform that helps ensure best practices and streamlines workflows to better ensure procedural proficiency,” said Collins. “I believe the company is well positioned to achieve rapid growth and I am looking forward to my association with them.”     Harrington is the owner of Denis L Harrington Consulting, LLC, a management and strategy consulting firm he established after nearly 30 years of successful leadership in the medical device industry. He previously served as CEO for BridgePoint Medical and NexGen Medical, successfully leading BridgePoint from its development stage through commercialization and successful acquisition by Boston Scientific. Currently, he serves as an executive consultant and board director for several medical device companies. “I am excited to join ExplORer Surgical’s Board of Directors,” commented Harrington. “I have spent over 30 years in the medical device business, and I am extremely impressed by ExplORer’s potential. As the healthcare ecosystem rapidly evolves and changes, platforms like ExplORer will play an increasingly critical role in delivering insight, information and best practices to optimize outcomes and improve efficiencies in all healthcare procedure suites. ExplORer’s ability to deliver remote coaching and constantly update itself for continuous automated improvement make it an indispensable tool for med-tech sales reps to support complex procedures and deliver optimized service.”

BridgePoint Medical Frequently Asked Questions (FAQ)

  • When was BridgePoint Medical founded?

    BridgePoint Medical was founded in 2002.

  • Where is BridgePoint Medical's headquarters?

    BridgePoint Medical's headquarters is located at 13355 10th Ave N, Plymouth.

  • What is BridgePoint Medical's latest funding round?

    BridgePoint Medical's latest funding round is Acquired.

  • How much did BridgePoint Medical raise?

    BridgePoint Medical raised a total of $26.2M.

  • Who are the investors of BridgePoint Medical?

    Investors of BridgePoint Medical include Boston Scientific, Polaris Partners, New Enterprise Associates, Flare Capital Partners and Michael Berman.

  • Who are BridgePoint Medical's competitors?

    Competitors of BridgePoint Medical include Bioheart, Uptake Medical, Aeris Therapeutics, MiCardia, Interventional Spine and 11 more.

Compare BridgePoint Medical to Competitors

C
Chestnut Medical Technologies

Chestnut Medical Technologies, Inc. was founded to pioneer new minimally invasive therapies for Interventional Neuroradiology. Chestnut aims to develop technologies that are easier to use while improving outcomes and reducing complications in the treatment of neurovascular disease.

D
Disc Dynamics

Disc Dynamics has developed the DASCORTM Disc Arthroplasty System, an innovative, minimally invasive nucleus replacement treatment for patients suffering from chronic low back pain caused by Degenerative Disc Disease (DDD).

NeoChord Logo
NeoChord

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. The company was founded in 2007 and is based in Minneapolis, Minnesota.

S
Spinal Restoration

Spinal Restoration restores patients' lives by delivering new therapies that address unmet needs in spine health management. These therapies are minimally invasive, early interventions with clinically proven results. The company is working with a diverse, highly regarded group of clinical and scientific advisors to develop and gain regulatory approval of the Biostat System, a proprietary resorbable biologic and delivery system for the treatment of chronic disc pain, based on solid scientific and clinical evidence.

MicroTransponder Logo
MicroTransponder

MicroTransponder is a global medical device company committed to developing research-based neuroscience solutions. The company focuses on restoring independence and dignity for people suffering from neurological conditions that impair sensory and motor function. MicroTransponder's FDA-approved Vivistim® Paired VNS™ System is a clinically-proven medical technology that generates more improvement in upper limb function than rehabilitation alone for stroke survivors after 6 weeks of in-clinic therapy. MicroTransponder was founded in 2007 and is based in Austin, Texas.

V
VytronUS

VytronUS is developing an integrated imaging and ablation platform for cardiac electrophysiologists. Harnessing the capability of ultrasound energy, the company's system creates a high resolution image of the interior of the heart for procedure planning and allows the physician to draw a desired treatment pattern on the image at the workstation.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.